title: [Men have smaller and more atherogenic LDL particles than women].
authors.affiliation: Tampereen kaupungin sosiaali- ja terveystoimi PL 98, 33201 Tampere. matti.nikkila@tt.tampere.fi
authors.forename: M
authors.initials: M
authors.lastname: Nikkilä
authors.forename: T
authors.initials: T
authors.lastname: Pitkäjärvi
authors.forename: P
authors.initials: P
authors.lastname: Laippala
authors.forename: T
authors.initials: T
authors.lastname: Koivula
authors.forename: T
authors.initials: T
authors.lastname: Solakivi
authors.forename: T
authors.initials: T
authors.lastname: Lehtimäki
authors.forename: H
authors.initials: H
authors.lastname: Jokela
authors.forename: E
authors.initials: E
authors.lastname: Lehtomäki
authors.forename: K
authors.initials: K
authors.lastname: Seppä
authors.forename: P
authors.initials: P
authors.lastname: Sillanaukee
mesh_terms: D000328:Adult; D000368:Aged; D001057:Apolipoproteins E / Q000235:genetics; D001161:Arteriosclerosis / Q000378:metabolism / Q000517:prevention & control; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008077:Lipoproteins, LDL / Q000097:blood / Q000502:physiology / Q000648:ultrastructure*; D008297:Male; D010316:Particle Size; D010641:Phenotype; D012737:Sex Factors
chemical_list: D001057:Apolipoproteins E; D000960:Hypolipidemic Agents; D008077:Lipoproteins, LDL